References
- Mulder DW, Lamber EH, Eaton LM. Myasthenic syndrome in patients with amyotrophic lateral sclerosis. Neurology. 1959;9:627–31.
- Restivo DA, Bianconi C, Ravenni R, DeGrandis D. ALS and myasthenia: an unusual association in a patient treated with riluzole. Muscle Nerve.2000;23:294–5.
- Howard FM Jr, Lennon VA, Finley J, Matsumato J, Elveback LR. Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis. Ann N Y Acad Sci. 1987;505:526–38.
- Okuyama Y, Mizuno T, Inoue H, Kimoto K. Amyotrophic lateral sclerosis with anti-acetylcholine receptor antibody. Intern Med. 1997;36:312–5.
- Noseworthy JH, Rae-Grant AD, Brown WF. An unusual subacute progressive motor neuronopathy with myasthenia-like features. Can J Neurol Sci. 1988;15:304–9.
- de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, . Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119:497–503.
- Daube JR. Electrodiagnostic studies in amyotrophic lateral sclerosis and other motor neuron disorders. Muscle Nerve. 2000;23:1488–502.
- Punga AR, Sawada M, Stålberg EV. Electrophysiological signs and the prevalence of adverse effects of acetylcholinesterase inhibitors in patients with myasthenia gravis. Muscle Nerve. 2008;37:300–7.